Germline Shelterin Loss of Function Predisposes to Lipoma and Uterine Leiomyoma: Population Evidence Bearing on Shelterin-Associated Sarcoma Risk
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Purpose
Germline shelterin variants were linked to sarcoma in a case-enriched cohort. Whether shelterin loss of function predisposes to mesenchymal neoplasia in the general population is unknown.
Methods
We analyzed rare-variant collapsing associations for five shelterin genes across neoplasm phenotypes in UK Biobank exomes, with Genebass as a second pipeline. Prespecified shelterin and centrosome gene sets were tested by permutation-calibrated statistics against a TP53 / RB1 / NF1 positive control. Carrier risks were compared with telomere-lengthening predictions.
Results
Lipoma risk was increased in TERF1 (odds ratio [OR], 3.32; P = 8.4 × 10⁻⁸), POT1 , and TERF2IP carriers, and uterine leiomyoma risk in all four core shelterin genes, most strongly POT1 (OR, 2.23; P = 4.0 × 10⁻⁵); POT1 and TINF2 reproduced in Genebass. TERF1 was also associated with thyroid cancer and monoclonal gammopathy. Neither gene set nor the positive control was associated with self-reported sarcoma. Telomere lengthening accounted for POT1 -associated chronic lymphocytic leukemia risk but not myeloma or TINF2 -associated thyroid cancer, where observed risk exceeded prediction five- to seven-fold.
Conclusion
Shelterin loss of function is a population-level risk factor for lipoma and uterine leiomyoma, the benign counterparts of liposarcoma and leiomyosarcoma. TERF1 joins POT1 and TINF2 as long-telomere cancer genes. Sarcoma-specific penetrance remains untested.